April 23, 2021 Comments Off on New patent for BDSI drug SYMPROIC Posted in: Patent Added Annual Drug Patent Expirations for SYMPROIC Symproic is a drug marketed by Bdsi and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent for BDSI drug SYMPROIC appeared first on DrugPatentWa…
April 23, 2021 Comments Off on New patent for Astrazeneca Ab drug FARXIGA Posted in: Patent Added Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are eighteen patents…
The post New patent for Astrazeneca Ab drug FARXIGA appeared first on …
